Silo Pharma Inc (SILO) — Strategic Asset Allocation Index
Silo Pharma Inc (SILO) has a Strategic Asset Allocation Index of 109.7% as of December 2017. Strategic assets (PP&E of $- plus long-term investments of $1.32 Million) total $1.32 Million, measured against net assets of $1.20 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Silo Pharma Inc (SILO) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Silo Pharma Inc Strategic Asset Allocation Index (2016–2017)
This chart shows how Silo Pharma Inc's Strategic Asset Allocation Index has evolved across 2 annual periods from 2016 to 2017. As of December 2017, the index stands at 109.7%, representing strategic assets of $1.32 Million against net assets of $1.20 Million USD. For live market cap and overall valuation, see Silo Pharma Inc market cap and net worth.
Annual Strategic Asset Allocation Index for Silo Pharma Inc (2016–2017)
The table below presents the year-by-year Strategic Asset Allocation Index for Silo Pharma Inc from 2016 to 2017, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Silo Pharma Inc (SILO) shareholders funds for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2017 | 109.7% | $1.32 Million | $- | $1.32 Million | $1.20 Million | ▲ +34.7 pp |
| 2016 | 75.0% | $634.87K | $- | $634.87K | $846.51K | — |